SE7713906L - Sett att framstella nya piperazinderivat - Google Patents

Sett att framstella nya piperazinderivat

Info

Publication number
SE7713906L
SE7713906L SE7713906A SE7713906A SE7713906L SE 7713906 L SE7713906 L SE 7713906L SE 7713906 A SE7713906 A SE 7713906A SE 7713906 A SE7713906 A SE 7713906A SE 7713906 L SE7713906 L SE 7713906L
Authority
SE
Sweden
Prior art keywords
way
produce new
piperazine derivatives
new piperazine
derivatives
Prior art date
Application number
SE7713906A
Other languages
English (en)
Other versions
SE430159B (sv
Inventor
K Felfoldi
J Apjok
M Bartok
J Czombos
A Molnar
F Noteisz
E Karpati
L Szporny
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Publication of SE7713906L publication Critical patent/SE7713906L/sv
Publication of SE430159B publication Critical patent/SE430159B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
    • C07D311/82—Xanthenes
    • C07D311/84—Xanthenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 9

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Anesthesiology (AREA)
  • Diabetes (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SE7713906A 1976-12-15 1977-12-07 Analogiforfarande for framstellning av nya piperidinderivat SE430159B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU76RI605A HU174215B (hu) 1976-12-15 1976-12-15 Sposob poluchenija novykh proizvodnykh piperazina i kislotnykh additivnykh i chetvjortichnykh solej

Publications (2)

Publication Number Publication Date
SE7713906L true SE7713906L (sv) 1978-06-16
SE430159B SE430159B (sv) 1983-10-24

Family

ID=11001009

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7713906A SE430159B (sv) 1976-12-15 1977-12-07 Analogiforfarande for framstellning av nya piperidinderivat

Country Status (21)

Country Link
US (2) US4140790A (sv)
JP (2) JPS6026114B2 (sv)
AT (1) AT359507B (sv)
BE (1) BE861849A (sv)
CA (1) CA1080219A (sv)
CH (1) CH632750A5 (sv)
DE (1) DE2755707A1 (sv)
ES (1) ES465061A1 (sv)
FI (1) FI65427C (sv)
FR (1) FR2374322A1 (sv)
GB (1) GB1580227A (sv)
HU (1) HU174215B (sv)
IL (1) IL53552A (sv)
IN (1) IN146474B (sv)
NL (1) NL7713827A (sv)
NO (1) NO147306C (sv)
PT (1) PT67403B (sv)
SE (1) SE430159B (sv)
SU (1) SU694071A3 (sv)
YU (1) YU293677A (sv)
ZA (1) ZA777398B (sv)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU174215B (hu) * 1976-12-15 1979-11-28 Richter Gedeon Vegyeszet Sposob poluchenija novykh proizvodnykh piperazina i kislotnykh additivnykh i chetvjortichnykh solej
US4703120A (en) * 1986-04-28 1987-10-27 Ortho Pharmaceutical Corporation Furo(3,4-d)pyrimidine-2,4-dione derivatives and intermediates thereof
CN1060168C (zh) * 1994-05-06 2001-01-03 中国人民解放军军事医学科学院毒物药物研究所 新的呫吨衍生物，其制备方法及含它们的药物组合物
WO2003064413A1 (en) 2002-02-01 2003-08-07 Astrazeneca Ab Quinazoline compounds
EP1611116A2 (en) * 2003-04-08 2006-01-04 Neuromed Technologies, Inc. Calcium channel inhibitors comprising benzhydril spaced from piperazine
US20080207738A1 (en) * 2007-02-28 2008-08-28 Cancure Laboratories, Llc Drug combinations to treat drug resistant tumors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3481930A (en) * 1966-11-21 1969-12-02 American Home Prod Xanthene and thioxanthene-9 ureas and propionamides
US3502662A (en) * 1968-03-18 1970-03-24 American Home Prod N-(9-xanthenyl or thioxanthenyl)-3-amino or iodo-propionamides and 4-(9-xanthenyl or thioxanthenyl)-thiosemicarbazones
FR2201084B1 (sv) * 1972-09-29 1975-10-31 Bouchara Emile
US3953449A (en) * 1973-05-09 1976-04-27 Synthelabo 2-(4-M-CF3 or -SCF3 phenylpiperazino)-ethyl benzoates
HU174215B (hu) * 1976-12-15 1979-11-28 Richter Gedeon Vegyeszet Sposob poluchenija novykh proizvodnykh piperazina i kislotnykh additivnykh i chetvjortichnykh solej

Also Published As

Publication number Publication date
BE861849A (fr) 1978-03-31
CH632750A5 (de) 1982-10-29
FR2374322B1 (sv) 1981-11-27
ES465061A1 (es) 1979-01-01
SE430159B (sv) 1983-10-24
IL53552A (en) 1981-07-31
US4140790A (en) 1979-02-20
NO147306C (no) 1983-03-16
FI773743A (fi) 1978-06-16
JPS5377080A (en) 1978-07-08
PT67403B (en) 1979-05-21
GB1580227A (en) 1980-11-26
IL53552A0 (en) 1978-03-10
NO774294L (no) 1978-06-16
YU293677A (en) 1982-08-31
HU174215B (hu) 1979-11-28
NL7713827A (nl) 1978-06-19
FR2374322A1 (fr) 1978-07-13
IN146474B (sv) 1979-06-16
AT359507B (de) 1980-11-10
PT67403A (en) 1978-01-01
CA1080219A (en) 1980-06-24
JPS5377073A (en) 1978-07-08
NO147306B (no) 1982-12-06
JPS6026114B2 (ja) 1985-06-21
ZA777398B (en) 1978-10-25
FI65427C (fi) 1984-05-10
ATA867677A (de) 1980-04-15
SU694071A3 (ru) 1979-10-25
US4250310A (en) 1981-02-10
DE2755707A1 (de) 1978-06-29
FI65427B (fi) 1984-01-31

Similar Documents

Publication Publication Date Title
SE441528B (sv) Sett att framstella nya 3-kinolin-karboxylsyraderivat
SE440779B (sv) Sett att framstella androstan-17-on-derivat
SE435928B (sv) Sett att framstella nya 3-aryl-oxazolidin-2-oner
SE7605925L (sv) Nya prostanderivat och sett att framstella desamma
SE427111B (sv) Sett att framstella pilokarpiniumsalter
SE430687B (sv) Sett att framstella hexanitrostilben
SE7602729L (sv) Sett att framstella nya indolylalkylpiperidiner
SE435280B (sv) Sett att framstella nya 0-(3-amino-2-hydroxipropyl)-amidoximderivat
SE434842B (sv) Sett att framstella nya 7-amino-tiazolyl-acetamido-cefalosporansyraderivat
SE436037B (sv) Sett att framstella nya 11-desoxi-prostaglandin-f?712-derivat
SE425312B (sv) Sett att framstella morfolinderivat
SE7511328L (sv) Sett att framstella nya pyridinderivat
SE420732B (sv) Sett att framstella 4-gonen-3-oner
SE7609426L (sv) Sett att framstella nya oxazolidinoner
SE7705986L (sv) Sett att framstella nya aryltrifluoretyaminer
SE434397B (sv) Sett att framstella bens-acyl-bensimidazol-2-derivat
SE7713906L (sv) Sett att framstella nya piperazinderivat
SE7711246L (sv) Piperazinderivat
SE7509209L (sv) Sett att framstella nya kinolinderivat
SE433213B (sv) Sett att framstella 2 -fenyl-3-amino-benso/b/tiofenderivat
SE7609666L (sv) Sett att framstella nya 5-aminometyltiazolderivat
SE7704055L (sv) Sett att framstella nya naftalenderivat
SE412233B (sv) Sett att framstella nya fenotiazinderivat
SE7613991L (sv) Sett att framstella nya substituerade indoler
SE415252B (sv) Sett att framstella nya oxifenylbutazonderivat